
|Articles|March 1, 2002
Pimecrolimus reactions low compared to tacrolimus
Miami Beach, Fla. - The acne war chests of dermatologists haveexpanded with new devices, including azelaic acid, retinoids, and oral antibiotics.The FDA has even added oral contraceptives to the armamentarium.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
3
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
4
Off-Label Case Series: Topical Roflumilast for Mild HS
5


















